Aurobindo Pharma plans to launch 50-60 products in US in FY21
Posted by
www.biotecnika.org
The company has received final approval for six ANDAs (abbreviated new
drug application) and launched four products in the fourth quarter of
last fiscal.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-plans-to-launch-50-60-products-in-us-in-fy21/articleshow/76509828.cms
Subscribe to:
Post Comments (Atom)
Post a Comment